IMARC Group's report titled "Osteosynthesis Devices Market by Type (Internal, External), Material (Non-Degradable, Degradable), Fracture Type (Patella, Tibia or Fibula or Ankle, Clavicle, Scapula or Humerus, Radius or Ulna, Hand, Wrist, Vertebral Column, Pelvis, Hip, Femur, Foot Bones, and Others), End User (Hospitals, Orthopedic Specialist Clinics, and Others), and Region 2024-2032". offers a comprehensive analysis of the industry, which comprises insights on the global osteosynthesis devices market trends. The global market size reached US$ 9.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.97% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/osteosynthesis-devices-market/requestsample
Factors Affecting the Growth of the Osteosynthesis Devices Industry:
Increasing Incidence of Bone Fractures:
The rising prevalence of bone fractures due to osteoporosis, falls, and degenerative bone diseases is propelling the growth of the market. As people are aging, their bones are becoming more fragile, increasing the likelihood of fractures even with minor trauma. Besides this, urbanization and changes in lifestyle are leading to an increase in accidents, sports injuries, and other trauma-related incidents, further contributing to the incidence of bone fractures. Activities like sports and recreational pursuits often involve physical strain and accidents, which can result in fractures.
Technological Advancements:
Innovations in engineering and design are leading to the development of osteosynthesis devices that offer enhanced biomechanical properties and better anatomical fit. Advancements, such as locking plates, intramedullary nails, and anatomically contoured implants, improve stability and promote faster healing. The use of advanced materials like titanium alloys, stainless steel, and biocompatible polymers is revolutionizing the field of osteosynthesis. These materials offer superior strength, corrosion resistance, and biocompatibility, reducing the risk of implant failure and enhancing patient outcomes.
Growing Preferences for Minimally Invasive (MI) Procedures:
Minimally invasive (MI) procedures involve smaller incisions compared to traditional open surgeries. This results in less disruption to surrounding soft tissues, leading to reduced pain, faster recovery times, and improved cosmetic outcomes for patients. MI techniques are also associated with lower rates of complications, such as infection, blood loss, and wound healing problems. This makes them particularly attractive for patients with comorbidities or those at higher risk of surgical complications.
Leading Companies Operating in the Global Osteosynthesis Devices Industry:
Arthrex Inc.
B. Braun Melsungen AG
Globus Medical Inc.
GS Medical USA
Johnson & Johnson
Life Spine Inc.
MicroPort Scientific Corporation
Neosteo SAS
Precision Spine Inc.
Smith & Nephew plc
Stryker Corporation
Zimmer Biomet
Osteosynthesis Devices Market Report Segmentation:
By Type:
Internal
Screw and Plates
Wires and Pins
Intramedullary Rods and Nails
Spinal Fixation Devices
External
Fracture Fixation
Bone Lengthening
Internal represents the largest segment on account of the utilization of internal fixation devices, such as plates, screws, and nails, for stabilizing fractures and offering superior biomechanical stability compared to external fixation methods.
By Material:
Non-Degradable
Degradable
Non-degradable accounts for the majority of the market share owing to its long-term mechanical support and stability to fractured bones, making it a preferred choice in orthopedic surgery.
By Fracture Type:
Patella, Tibia or Fibula or Ankle
Clavicle, Scapula or Humerus
Radius or Ulna
Hand, Wrist
Vertebral Column
Pelvis
Hip
Femur
Foot Bones
Others
Patella, tibia, or fibula, and ankle exhibit a clear dominance in the market due to their high incidence rates and the necessity for effective stabilization to ensure proper healing and functional recovery.
By End User:
Hospitals
Orthopedic Specialist Clinics
Others
Hospitals hold the biggest market share as they serve as primary facilities for orthopedic surgeries and trauma care, where a significant volume of osteosynthesis procedures are performed regularly, necessitating the use of osteosynthesis devices.
Regional Insights:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
North America enjoys the leading position in the osteosynthesis devices market, driven by well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and a growing prevalence of orthopedic conditions in the region.
Global Osteosynthesis Devices Market Trends:
There is a growing emphasis on the use of biocompatible materials in osteosynthesis devices to minimize the risk of adverse reactions and improve patient safety. This includes the development of implants made from titanium alloys, stainless steel, and biodegradable polymers. In addition, healthcare providers are focusing on delivering value-based care, emphasizing improved patient outcomes and cost-effectiveness. This is leading to greater scrutiny of the clinical and economic outcomes associated with different osteosynthesis devices, influencing purchasing decisions.
Furthermore, digital technologies, such as 3D printing, robotic-assisted surgery, and smart implants, are integrated into osteosynthesis devices, enabling personalized treatments, real-time monitoring, and enhanced surgical precision.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163